Title:
Heteroaromatic compounds as Bruton's tyrosine kinase (BTK) inhibitors
Document Type and Number:
Japanese Patent JP6348492
Kind Code:
B2
Abstract:
wherein the groups A, Cy, X1 and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.
Inventors:
Benttween, Jörg Martin
Berry, Angela Kai
Bosanac, Todd
Burke, Michael Jason
Disalvo, Darren Todd
Horan, Joshua Courtney
Liang, Xuan
Mao, Kang
Mao, Wan
SHEN,Yue
Soleil Manzade, Fariba
Sindel, Lenny Em
Berry, Angela Kai
Bosanac, Todd
Burke, Michael Jason
Disalvo, Darren Todd
Horan, Joshua Courtney
Liang, Xuan
Mao, Kang
Mao, Wan
SHEN,Yue
Soleil Manzade, Fariba
Sindel, Lenny Em
Application Number:
JP2015526696A
Publication Date:
June 27, 2018
Filing Date:
August 08, 2013
Export Citation:
Assignee:
Boehringer Ingelheim International GmbH
International Classes:
C07D231/38; A61K31/415; A61K31/4155; A61K31/427; A61K31/438; A61K31/4439; A61K31/454; A61K31/4545; A61K31/5377; A61P1/04; A61P11/02; A61P11/06; A61P17/00; A61P17/04; A61P19/02; A61P27/02; A61P29/00; A61P35/02; A61P37/06; A61P37/08; A61P43/00; C07D401/04; C07D401/06; C07D401/14; C07D403/04; C07D403/06; C07D405/14; C07D413/14; C07D417/04; C07D417/06
Domestic Patent References:
| JP2000509035A | ||||
| JP2008528661A | ||||
| JP2012516329A | ||||
| JP2009536617A | ||||
| JP2006515828A | ||||
| JP2005504767A | ||||
| JP2010526768A |
Foreign References:
| WO2010055304A1 | ||||
| WO2012021615A1 |
Attorney, Agent or Firm:
Patent business corporation Tsukuni